Drugs / Riluzole 50 MG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01378676 Background | Jun 2011 → Mar 2012 | amyotrophic lateral sclerosis | Cytokinetics | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Riluzole 50 MG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01378676 ↗ |